This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tianjin Institute of Pharmaceutical Research. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Jianwu Wang: Innovator in Pharmaceutical Research
Introduction: Jianwu Wang is an esteemed inventor based in Tianjin, China. His contributions to the field of medicine, particularly in treating diseases associated with inflammation, immunity, and infection, have garnered attention within the scientific community. With a focus on glycyrrhetinic acid-30-amide derivatives, Wang's work exemplifies the intersection of innovation and pharmaceutical research.
Latest Patents: Jianwu Wang holds a patent for "Glycyrrhetinic acid-30-amide derivatives and their use." This invention involves a pharmaceutical composition that exhibits remarkable properties such as anti-inflammatory, analgesic, anti-allergic, cough-preventing, liver-protecting, and anti-viral effects. The derivatives and their preparation are outlined in detail in the patent, making significant contributions to therapeutic approaches in modern medicine.
Career Highlights: Currently, Jianwu Wang works at the Tianjin Institute of Pharmaceutical Research. His role at this institution allows him to engage in cutting-edge research, pushing the boundaries of pharmaceutical science. His dedication to developing innovative solutions for complex health issues demonstrates his commitment to improving patient outcomes.
Collaborations: Jianwu Wang collaborates with several notable colleagues, including Weiren Xu and Jianping Wong. These partnerships facilitate knowledge sharing and collective problem-solving, further enhancing the impact of their research and innovations in the field.
Conclusion: Jianwu Wang's innovative work in the development of glycyrrhetinic acid-30-amide derivatives showcases the vital role inventors play in advancing medical science. Through his research at the Tianjin Institute of Pharmaceutical Research and collaboration with esteemed colleagues, Wang continues to contribute to transformative solutions aimed at addressing significant health challenges. His patent exemplifies the importance of innovation in the pharmaceutical industry and its potential to improve lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile